Search

Your search keyword '"Russo, Juan J"' showing total 170 results

Search Constraints

Start Over You searched for: Author "Russo, Juan J" Remove constraint Author: "Russo, Juan J"
170 results on '"Russo, Juan J"'

Search Results

1. Inotropes, vasopressors, and mechanical circulatory support for treatment of cardiogenic shock complicating myocardial infarction: a systematic review and network meta-analysis

3. Association Between the Access Site for Coronary Angiography and Catheter-induced Coronary Artery Dissection

4. Arrhythmic Events and Mortality in Patients With Cardiogenic Shock on Inotropic Support: Results of the DOREMI Randomized Trial

5. List of contributors

6. Modifiable Risk Factors and Residual Risk Following Coronary Revascularization: Insights From a Regionalized Dedicated Follow-Up Clinic

7. Coronary Stenting

12. Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Clinical Practice Update on Optimal Post Cardiac Arrest and Refractory Cardiac Arrest Patient Care

13. Impact of mean arterial pressure on clinical outcomes in comatose survivors of out-of-hospital cardiac arrest: Insights from the University of Ottawa Heart Institute Regional Cardiac Arrest Registry (CAPITAL-CARe)

15. Safety and Efficacy of Staged Percutaneous Coronary Intervention During Index Admission for ST-Elevation Myocardial Infarction With Multivessel Coronary Disease (Insights from the University of Ottawa Heart Institute STEMI Registry)

17. Coronary Stenting

18. Inhaled anaesthesia compared with conventional sedation in post cardiac arrest patients undergoing temperature control: A systematic review and meta-analysis

22. Duration of dual antiplatelet therapy and associated outcomes following percutaneous coronary intervention for acute myocardial infarction: contemporary practice insights from the Canadian Observational Antiplatelet Study

24. Safety of same-day discharge in patients with left main percutaneous intervention

25. Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: Insights from the TIGRIS registry

27. Implications of Myocardial Infarction on Management and Outcome in Cardiogenic Shock

29. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock

30. Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial

31. Transradial Versus Transfemoral Access for Percutaneous Coronary Intervention in ST-Segment–Elevation Myocardial Infarction

32. Performance of Plasma Adenosine as a Biomarker for Predicting Cardiovascular Risk

33. Abstract 339: Relationship Between Post-arrest Care Hemodynamics and Cerebral Oxygen Saturation in Comatose Survivors of Out-of-hospital Cardiac Arrest: Insights From the CAPITAL-RETURN Trial

34. Abstract 338: Relationship Between Post-arrest Care Cardiac Index and Clinical Outcomes in Comatose Survivors of Out-of-hospital Cardiac Arrest: Insights From the CAPITAL-RETURN Trial

35. Abstract 125: Capital Do-Re-Mi: A Randomized Trial of Dobutamine Compared to Milrinone in Cardiogenic Shock

36. Outcomes of retrograde chronic total occlusion percutaneous coronary intervention: A report from the OPEN‐CTO registry

37. Contrast-free optical coherence tomography:Systematic evaluation of non-contrast media for intravascular assessment

38. Methodological Rigor in Preclinical Cardiovascular Studies

40. Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial.

41. Physician prediction of 1-year mortality in the cardiac catheterization laboratory: comparison to a validated risk score.

42. Outcomes with retrograde versus antegrade chronic total occlusion revascularization

43. Improvement in left ventricular function following higher‐risk percutaneous coronary intervention in patients with ischemic cardiomyopathy

44. Evaluation of Plasma Adenosine as a Marker of Cardiovascular Risk: Analytical and Biological Considerations

45. Adenosine as a Marker and Mediator of Cardiovascular Homeostasis: A Translational Perspective

46. Reply

47. Outcomes of retrograde chronic total occlusion percutaneous coronary intervention: A report from the OPEN‐CTO registry.

48. Performance of Plasma Adenosine as a Biomarker for Predicting Cardiovascular Risk.

49. Progenitor Cells for Arterial Repair: Incremental Advancements towards Therapeutic Reality

Catalog

Books, media, physical & digital resources